The Role of Neuromuscular Blockade in Patients with Traumatic Brain Injury: A Systematic Review

Neurocritical Care

Volumn 22, Issue 2, 2015, Pages 325-334

  Sanfilippo, Filippo ^a,b   Santonocito, Cristina ^c,i   Veenith, Tonny ^b,d   Astuto, Marinella ^e   Maybauer, Marc O ^f,g,h  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF CATANIA   (Italy)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h University of Texas Medical Branch School of Medicine   (United States)

ⁱ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Critical care; Critical illness; Head injury; Intensive care; Intracranial pressure; Myopathy; Neuromuscular blocking agents; Polyneuropathy

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; DIMETHYLTUBOCURARINE; DOXACURIUM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PIPECURONIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CONTINUOUS INFUSION; CRITICAL ILLNESS; DRUG EFFICACY; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; ENERGY EXPENDITURE; FEVER; HUMAN; INFLAMMATION; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; LENGTH OF STAY; LONG TERM CARE; LUNG INJURY; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NEUROMUSCULAR BLOCKING; NONHUMAN; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SEIZURE; SYSTEMATIC REVIEW; TRACHEOBRONCHIAL TOILET; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; WEAKNESS; ADVERSE EFFECTS; ANIMAL; BRAIN INJURIES; PROCEDURES;

ANIMALS; BRAIN INJURIES; HUMANS; NEUROMUSCULAR BLOCKADE;

EID: 84943015368     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-014-0061-1     Document Type: Article

References (82)

1. Fleminger S, Ponsford J. Long term outcome after traumatic brain injury. BMJ (Clinical research ed). 2005;331:1419–20.
2. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma. 2007;24(Suppl 1):S55–8.
3. Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: intensive care management. Br J Anaesth. 2007;99:32–42.
4. Matta B, Menon D. Severe head injury in the United Kingdom and Ireland: a survey of practice and implications for management. Crit Care Med. 1996;24:1743–8.
5. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107–16.
6. Needham CJ, Brindley PG. Best evidence in critical care medicine: the role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Can J anaesth. 2012;59:105–8.
7. Steingrub JS, Lagu T, Rothberg MB, Nathanson BH, Raghunathan K, Lindenauer PK. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis*. Crit Care Med. 2014;42:90–6.
8. White PF, Schlobohm RM, Pitts LH, Lindauer JM. A randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning. Anesthesiology. 1982;57:242–4.
9. Werba A, Klezl M, Schramm W, et al. The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia. 1993;48:301–3.
10. Werba A, Weinstabl C, Petricek W, Plainer B, Spiss CK. [Requisite muscle relaxation using vecuronium for tracheobronchial suction in neurosurgical intensive care patients]. Der Anaesthesist. 1991;40:328–31.
11. Kerr ME, Sereika SM, Orndoff P, et al. Effect of neuromuscular blockers and opiates on the cerebrovascular response to endotracheal suctioning in adults with severe head injuries. Am J Crit Care. 1998;7:205–17.
12. Chivite Fernandez N, Martinez Oroz A, Marraco Bonmcompte M, et al. [Intracranial pressure response during secretion aspiration after administration of a muscle relaxant]. Enfermeria intensiva/Sociedad Espanola de Enfermeria Intensiva y Unidades Coronarias 2005;16:143-52.
13. McCall M, Jeejeebhoy K, Pencharz P, Moulton R. Effect of neuromuscular blockade on energy expenditure in patients with severe head injury. JPEN. 2003;27:27–35.
14. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998;338:20–4.
15. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33:1876–91.
16. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10:931–41.
17. de Jonghe B, Lacherade JC, Sharshar T, Outin H. Intensive care unit-acquired weakness: risk factors and prevention. Crit Care Med. 2009;37:S309–15.
18. Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care. 2005;11:381–90.
19. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 2009;339:b2700.
20. Kerwin AJ, Croce MA, Timmons SD, Maxwell RA, Malhotra AK, Fabian TC. Effects of fiberoptic bronchoscopy on intracranial pressure in patients with brain injury: a prospective clinical study. J Trauma. 2000;48:878–82 discussion 82–3.
21. Brown MM, Parr MJ, Manara AR. The effect of suxamethonium on intracranial pressure and cerebral perfusion pressure in patients with severe head injuries following blunt trauma. Eur J Anaesthesiol. 1996;13:474–7.
22. Schramm WM, Jesenko R, Bartunek A, Gilly H. Effects of cisatracurium on cerebral and cardiovascular hemodynamics in patients with severe brain injury. Acta Anaesthesiol Scand. 1997;41:1319–23.
23. Prielipp RC, Robinson JC, Wilson JA, MacGregor DA, Scuderi PE. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients. Crit Care Med. 1997;25:1236–41.
24. Minton MD, Grosslight K, Stirt JA, Bedford RF. Increases in intracranial pressure from succinylcholine: prevention by prior nondepolarizing blockade. Anesthesiology. 1986;65:165–9.
25. Stirt JA, Grosslight KR, Bedford RF, Vollmer D. “Defasciculation” with metocurine prevents succinylcholine-induced increases in intracranial pressure. Anesthesiology. 1987;67:50–3.
26. Kovarik WD, Mayberg TS, Lam AM, Mathisen TL, Winn HR. Succinylcholine does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram in patients with neurologic injury. Anesth Analg. 1994;78:469–73.
27. Schramm WM, Papousek A, Michalek-Sauberer A, Czech T, Illievich U. The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients. Anesth Analg. 1998;86:123–7.
28. Cafiero T, Razzino S, Mastronardi P, Mazzarella B, De Vivo P. Mivacurium in patients with intracranial pathology. Minerva Anestesiol. 1999;65:81–5.
29. Di Giugno G, Sanfilippo M, Orfei P, Rosa G. [Myorelaxants and intracranial pressure (ICP) in neurosurgery. Preliminary clinical results of pipecurium bromide (Arduan) on ICP and on cerebral perfusion pressure (CPP)]. Minerva Anestesiol. 1992;58:83–6.
30. Minton MD, Stirt JA, Bedford RF, Haworth C. Intracranial pressure after atracurium in neurosurgical patients. Anesth Analg. 1985;64:1113–6.
31. Rosa G, Orfei P, Sanfilippo M, Vilardi V, Gasparetto A. The effects of atracurium besylate (Tracrium) on intracranial pressure and cerebral perfusion pressure. Anesth Analg. 1986;65:381–4.
32. Rosa G, Sanfilippo M, Orfei P, et al. The effects of pipecuronium bromide on intracranial pressure and cerebral perfusion pressure. J Neurosurg Anesthesiol. 1991;3:253–7.
33. Rosa G, Sanfilippo M, Vilardi V, Orfei P, Gasparetto A. Effects of vecuronium bromide on intracranial pressure and cerebral perfusion pressure. A preliminary report. Br J Anaesth. 1986;58:437–40.
34. Schramm WM, Strasser K, Bartunek A, Gilly H, Spiss CK. Effects of rocuronium and vecuronium on intracranial pressure, mean arterial pressure and heart rate in neurosurgical patients. Br J Anaesth. 1996;77:607–11.
35. Unni VK, Gray WJ, Young HS. Effects of atracurium on intracranial pressure in man. Anaesthesia. 1986;41:1047–9.
36. Hsiang JK, Chesnut RM, Crisp CB, Klauber MR, Blunt BA, Marshall LF. Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary? Crit Care Med. 1994;22:1471–6.
37. Juul N, Morris GF, Marshall SB, Marshall LF. Neuromuscular blocking agents in neurointensive care. Acta Neurochir Suppl. 2000;76:467–70.
38. Cottrell JE, Hartung J, Giffin JP, Shwiry B. Intracranial and hemodynamic changes after succinylcholine administration in cats. Anesth Analg. 1983;62:1006–9.
39. Thiagarajah S, Sophie S, Lear E, Azar I, Frost EA. Effect of suxamethonium on the ICP of cats with and without thiopentone pretreatment. Br J Anaesth. 1988;60:157–60.
40. Giffin JP, Hartung J, Cottrell JE, Capuano C, Shwiry B. Effect of vecuronium on intracranial pressure, mean arterial pressure and heart rate in cats. Br J Anaesth. 1986;58:441–3.
41. Giffin JP, Litwak B, Cottrell JE, Hartung J, Capuano C. Intracranial pressure mean arterial pressure and heart rate after rapid paralysis with atracurium in cats. Can Anaesth Soc J. 1985;32:618–21.
42. Haigh JD, Nemoto EM, DeWolf AM, Bleyaert AL. Comparison of the effects of succinylcholine and atracurium on intracranial pressure in monkeys with intracranial hypertension. Can Anaesth Soc J. 1986;33:421–6.
43. Ducey JP, Deppe SA, Foley KT. A comparison of the effects of suxamethonium, atracurium and vecuronium on intracranial haemodynamics in swine. Anaesth Intensive Care. 1989;17:448–55.
44. Lanier WL, Milde JH, Michenfelder JD. The cerebral effects of pancuronium and atracurium in halothane-anesthetized dogs. Anesthesiology. 1985;63:589–97.
45. Vesely R, Hoffman WE, Gil KS, Albrecht RF, Miletich DJ. The cerebrovascular effects of curare and histamine in the rat. Anesthesiology. 1987;66:519–23.
46. Jacka MJ, Zygun D. Survey of management of severe head injury in Canada. Can J Neurol Sci. 2007;34:307–12.
47. Mehta S, Burry L, Fischer S, et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med. 2006;34:374–80.
48. Rhoney DH, Murry KR. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med. 2003;18:139–45.
49. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002;30:142–56.
50. Bohman LE, Heuer GG, Macyszyn L, et al. Medical management of compromised brain oxygen in patients with severe traumatic brain injury. Neurocrit Care. 2011;14:361–9.
51. Nangunoori R, Maloney-Wilensky E, Stiefel M, et al. Brain tissue oxygen-based therapy and outcome after severe traumatic brain injury: a systematic literature review. Neurocrit Care. 2012;17:131–8.
52. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med. 2010;363:1176–80.
53. Childs C. Human brain temperature: regulation, measurement and relationship with cerebral trauma: part 1. Br J Neurosurg. 2008;22:486–96.
54. Childs C, Wieloch T, Lecky F, Machin G, Harris B, Stocchetti N. Report of a consensus meeting on human brain temperature after severe traumatic brain injury: its measurement and management during pyrexia. Front Neurol. 2010;1:146.
55. Li J, Jiang JY. Chinese Head Trauma Data Bank: effect of hyperthermia on the outcome of acute head trauma patients. J Neurotrauma. 2012;29:96–100.
56. Manthous CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995;151:10–4.
57. Hata JS, Shelsky CR, Hindman BJ, Smith TC, Simmons JS, Todd MM. A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury. Neurocrit Care. 2008;9:37–44.
58. McCullough JN, Zhang N, Reich DL, et al. Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg. 1999;67:1895–9 discussion 919–21.
59. Nilsson L, Kogure K, Busto R. Effects of hypothermia and hyperthermia on brain energy metabolism. Acta Anaesthesiol Scand. 1975;19:199–205.
60. Rosomoff HL, Holaday DA. Cerebral blood flow and cerebral oxygen consumption during hypothermia. Am J Physiol. 1954;179:85–8.
61. Andrews PJ, Sinclair HL, Battison CG, et al. European society of intensive care medicine study of therapeutic hypothermia (32–35 degrees C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial). Trials. 2011;12:8.
62. http://clinicaltrials.gov/ct2/show/NCT00987688. The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury (POLAR-RCT). ClinicalTrials.gov Identifier: NCT00987688.
63. Quilez ME, Lopez-Aguilar J, Blanch L. Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation. Curr Opin Crit Care. 2012;18:23–8.
64. Pelosi P, Rocco PR. The lung and the brain: a dangerous cross-talk. Crit Care (London, England). 2011;15:168.
65. Morandi A, Brummel NE, Ely EW. Sedation, delirium and mechanical ventilation: the ‘ABCDE’ approach. Curr Opin Crit Care. 2011;17:43–9.
66. Bahloul M, Chaari AN, Kallel H, et al. Neurogenic pulmonary edema due to traumatic brain injury: evidence of cardiac dysfunction. Am J Crit Care. 2006;15:462–70.
67. Brambrink AM, Tzanova I. Neurogenic pulmonary edema after generalized epileptic seizure. Eur J Emerg Med. 1998;5:59–66.
68. Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med. 2002;28:1012–23.
69. Forel JM, Roch A, Marin V, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2006;34:2749–57.
70. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit care. 2002;8:101–5.
71. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, De Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;274:1221–5.
72. Leijten FS, De Weerd AW, Poortvliet DC, De Ridder VA, Ulrich C, Harink-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med. 1996;22:856–61.
73. Lazaridis C, DeSantis SM, McLawhorn M, Krishna V. Liberation of neurosurgical patients from mechanical ventilation and tracheostomy in neurocritical care. J Crit Care. 2012;27(417):e1–8.
74. Andelic N, Bautz-Holter E, Ronning P, et al. Does an early onset and continuous chain of rehabilitation improve the long-term functional outcome of patients with severe traumatic brain injury? J Neurotrauma. 2012;29:66–74.
75. Temkin NR, Dikmen SS, Winn HR. Management of head injury. Posttraumatic seizures. Neurosurg Clin N Am. 1991;2:425–35.
76. Yablon SA. Posttraumatic seizures. Arch Phys Med Rehabil. 1993;74:983–1001.
77. Standaert FG. Magic bullets, science, and medicine. Anesthesiology. 1985;63:577–8.
78. Ingram MD, Sclabassi RJ, Cook DR, Stiller RL, Bennett MH. Cardiovascular and electroencephalographic effects of laudanosine in “nephrectomized” cats. Br J Anaesth. 1986;58(Suppl 1):14S–8S.
79. Cardone C, Szenohradszky J, Yost S, Bickler PE. Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity. Anesthesiology. 1994;80:1155–61 discussion 29A.
80. Gwinnutt CL, Eddleston JM, Edwards D, Pollard BJ. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth. 1990;65:829–32.
81. Haddad S. Tachyphylaxis to cisatracurium—case reports and literature review. Middle East J Anesthesiol. 2008;19:1079–92.
82. Fish DN, Singletary TJ. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient. Pharmacotherapy. 1997;17:1322–7.